Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oppenheimer Holdings (OPY) Asset Writedowns and Impairment: 2019-2025

Historic Asset Writedowns and Impairment for Oppenheimer Holdings (OPY) over the last 6 years, with Sep 2025 value amounting to -$17,000.

  • Oppenheimer Holdings' Asset Writedowns and Impairment fell 240.00% to -$17,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $329,000, marking a year-over-year increase of 316.45%. This contributed to the annual value of $222,000 for FY2024, which is 4540.00% up from last year.
  • Oppenheimer Holdings' Asset Writedowns and Impairment amounted to -$17,000 in Q3 2025, which was down 525.00% from $4,000 recorded in Q2 2025.
  • Over the past 5 years, Oppenheimer Holdings' Asset Writedowns and Impairment peaked at $1.5 million during Q1 2021, and registered a low of -$3.0 million during Q4 2022.
  • Its 3-year average for Asset Writedowns and Impairment is $19,400, with a median of -$500 in 2024.
  • In the last 5 years, Oppenheimer Holdings' Asset Writedowns and Impairment crashed by 2,150.75% in 2022 and then skyrocketed by 1,700.00% in 2024.
  • Over the past 5 years, Oppenheimer Holdings' Asset Writedowns and Impairment (Quarterly) stood at -$134,000 in 2021, then plummeted by 2,150.75% to -$3.0 million in 2022, then soared by 99.27% to -$22,000 in 2023, then spiked by 1,700.00% to $352,000 in 2024, then slumped by 240.00% to -$17,000 in 2025.
  • Its Asset Writedowns and Impairment was -$17,000 in Q3 2025, compared to $4,000 in Q2 2025 and -$10,000 in Q1 2025.